Home NDC 66689-105-02 THYQUIDITY
Product NDC 66689-105
Requested package NDC 66689-105-02
11-digit product format 666890105
Labeler code 66689
Product ID 66689-105_24ae0fe1-3627-4fb9-a5b7-d186aa3e01cb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Levothyroxine Sodium
Dosage form SOLUTION
Route ORAL
Labeler VistaPharm, Inc.
Application NDA214047
Marketing category NDA
Marketing start 2021-02-15
Marketing end 2024-07-31
Substance LEVOTHYROXINE SODIUM
Active strength 100 ug/5mL
Pharmacologic classes Thyroxine [CS], l-Thyroxine [EPC]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 11 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N214047-001 THYQUIDITY LEVOTHYROXINE SODIUM 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N214047-001 9050307 2031-08-06 Drug product 2020-12-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 8869cabd3fbd…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214047-001 THYQUIDITY 100MCG/5ML SOLUTION / ORAL RLD, RS 2020-11-30 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 5aa47cf7b7d7…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214047-001 9050307 2031-08-06 Drug product 2020-12-14 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join THYQUIDITY LEVOTHYROXINE SODIUM Oliva Therapeutics, LLC 0c839877-50e4-455f-9b6c-462efb09cb96 2025-07-03 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 214047 application number: NDA214047
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 66689-105-02 66689010502 2 CARTON in 1 CARTON (66689-105-02) > 1 BOTTLE, GLASS in 1 CARTON > 100 mL in 1 BOTTLE, GLASS 2 carton 2021-02-15 2024-07-31 No No Current